Seoul
South Korea
6
2025-06-12
3
2026-03-10
These are the the leading inventors for applications assigned to NEXEL CO., LTD.:
NEXEL CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
RECOMBINANT PROTEIN FOR ULCERATIVE COLITIS TREATMENT OR PREVENTION AND COMPOSITION FOR ULCERATIVE COLITIS TREATMENT OR PREVENTION CONTAINING THE SAME
#2 | 2024-02-01POLYPEPTIDE FOR PREVENTING OR TREATING IDIOPATHIC PULMONARY FIBROSIS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#3 | 2023-09-21 ✅ Patent 12,571,791 granted on 2026-03-10METHODS FOR EVALUATING CARDIAC SAFETY OF DRUG USING CARDIOMYOCYTES DERIVED FROM HUMAN STEM CELLS
#4 | 2023-09-21METHOD FOR PRODUCING HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIAC ORGANOIDS AND HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIAC ORGANOIDS PRODUCED THEREBY
#5 | 2021-12-16 ✅ Patent 12,139,518 granted on 2024-11-12Compositions and methods for treating or preventing fibrosis
#6 | 2018-11-22 ✅ Patent 11,028,139 granted on 2021-06-08Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same
Also check out NEXEL CO., LTD.'s (Seoul, South Korea) applicant profile with 5 patent applications submitted.
142004 ⎘